CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

CordenPharma nomina il Dott. Jean-Luc Herbeaux Amministratore Delegato per guidare la prossima fase di crescita

Positive
AI Analysis

Summary

CordenPharma appointed Dr. Jean-Luc Herbeaux as CEO effective October 1, 2026, with incumbent Michael Quirmbach transitioning to Board Member and Senior Advisor roles.

Importance:2/10
Sentiment:
0.30
management changeCEO appointmentleadership transition

Read the original article

Published by PR Newswire Biotech on September 16, 2026 5:55 AM

Read Original